Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Combined familial hyperlipidemia with VLDL overproduction is a group of disorder in which mutations cause an enhanced production and secretion of VLDL into plasma.
| 1. |
Pajukanta P et al. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). 
|
| 2. |
Coon H et al. (2005) Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
|
| 3. |
Aouizerat BE et al. (1999) A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
|
| 4. |
Bodnar JS et al. (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1.
|
| 5. |
Pajukanta P et al. (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.
|
| 6. |
Castellani LW et al. (1998) Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.
|
| 7. |
Pei W et al. (2000) Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families.
|
| 8. |
Pajukanta P et al. (2001) Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL.
|
| 9. |
Huertas-Vázquez A et al. (2004) Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
|
| 10. |
OMIM.ORG article Omim 602491
|
 |
Copyright © 2005-2025 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |
